• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何在经济评估中计算间接成本。

How to calculate indirect costs in economic evaluations.

作者信息

Liljas B

机构信息

Department of Economics, Lund University, Sweden.

出版信息

Pharmacoeconomics. 1998 Jan;13(1 Pt 1):1-7. doi: 10.2165/00019053-199813010-00001.

DOI:10.2165/00019053-199813010-00001
PMID:10175982
Abstract

This article describes the components that should be included as indirect costs to be consistent with economic theory in studies conducted from a societal perspective. The recently proposed method of how to estimate indirect costs, the friction-cost approach, is shown to exclude many aspects of these indirect cost components. Furthermore, it is demonstrated that this approach rests on very strong assumptions about the individual's valuation of leisure and about the labour market. This approach does not, in most realistic circumstances, have a foundation in economic theory. It also shows that all indirect costs cannot be assumed to be included in the individual's reported utility weight for a health state [used to determine quality-adjusted life-year (QALY) values], as recently suggested by the US Panel for Cost-Effectiveness Analysis of Health and Medicine. Therefore, to be consistent with economic theory, neither the friction-cost approach nor the QALY approach can be recommended over the more commonly used human capital-cost approach for estimating the indirect costs of a disease in economic evaluations from a societal perspective.

摘要

本文描述了从社会角度进行的研究中,为与经济理论保持一致应作为间接成本纳入的组成部分。最近提出的估算间接成本的方法,即摩擦成本法,被证明排除了这些间接成本组成部分的许多方面。此外,还表明这种方法基于关于个人对休闲的估值以及劳动力市场的非常强的假设。在大多数现实情况下,这种方法在经济理论中缺乏依据。文章还表明,不能像美国卫生与医学成本效益分析小组最近所建议的那样,假定所有间接成本都包含在个人报告的健康状态效用权重中(用于确定质量调整生命年,即QALY值)。因此,为与经济理论保持一致,在从社会角度进行的经济评估中估算疾病的间接成本时,无论是摩擦成本法还是QALY法,都不能比更常用的人力资本成本法更值得推荐。

相似文献

1
How to calculate indirect costs in economic evaluations.如何在经济评估中计算间接成本。
Pharmacoeconomics. 1998 Jan;13(1 Pt 1):1-7. doi: 10.2165/00019053-199813010-00001.
2
Considering the societal perspective in economic evaluations: a systematic review in the case of depression.经济评估中的社会视角考量:抑郁症案例的系统评价
Health Econ Rev. 2020 Sep 22;10(1):32. doi: 10.1186/s13561-020-00288-7.
3
The friction cost method: a comment.摩擦成本法:一则评论。
J Health Econ. 1997 Apr;16(2):249-55; discussion 257-9. doi: 10.1016/s0167-6296(97)00006-4.
4
Indirect costs of back pain in the Netherlands: a comparison of the human capital method with the friction cost method.荷兰背痛的间接成本:人力资本法与摩擦成本法的比较
Pain. 1999 Mar;80(1-2):201-7. doi: 10.1016/s0304-3959(98)00204-8.
5
Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method.基于机会成本和代理商品法的非正规护理成本测量、评估和估算的标准化问卷。
Appl Health Econ Health Policy. 2019 Feb;17(1):15-24. doi: 10.1007/s40258-018-0418-2.
6
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.质量调整生命年在儿科护理中缺乏质量:对已发表的儿童健康成本效用研究的批判性综述。
Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127.
7
The friction-cost method : replacement for nothing and leisure for free?摩擦成本法:无偿替代与免费休闲?
Pharmacoeconomics. 2005;23(2):105-11. doi: 10.2165/00019053-200523020-00002.
8
Measuring indirect costs: is there a problem?衡量间接成本:存在问题吗?
Appl Health Econ Health Policy. 2003;2(3):135-9.
9
[Indirect costs in health technology assessment].[卫生技术评估中的间接成本]
Pol Merkur Lekarski. 2010 Jan;28(163):42-5.
10
The economic burden of informal care.非正式护理的经济负担。
Int J Technol Assess Health Care. 2002 Winter;18(1):46-54.

引用本文的文献

1
Systematic review of cost effectiveness and budget impact of artificial intelligence in healthcare.人工智能在医疗保健领域成本效益和预算影响的系统评价
NPJ Digit Med. 2025 Aug 26;8(1):548. doi: 10.1038/s41746-025-01722-y.
2
Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UK.英国慢性阻塞性肺疾病患者新型单吸入器三联疗法的经济学分析
Int J Chron Obstruct Pulmon Dis. 2025 Aug 7;20:2727-2743. doi: 10.2147/COPD.S475748. eCollection 2025.
3
Cost-Effectiveness of Single-Inhaler Versus Multiple-Inhaler Triple Therapy in COPD: A German Healthcare Perspective.
慢性阻塞性肺疾病中单一吸入器与多吸入器三联疗法的成本效益:德国医疗保健视角
Int J Chron Obstruct Pulmon Dis. 2025 Jun 19;20:2011-2022. doi: 10.2147/COPD.S492524. eCollection 2025.
4
Different attitudes towards estimating indirect costs of disease: The example of cancer.对疾病间接成本估算的不同态度:以癌症为例。
J Public Health Res. 2025 Apr 17;14(2):22799036251326636. doi: 10.1177/22799036251326636. eCollection 2025 Apr.
5
Cost Utility Analysis of Internet-Based Cognitive Behavioral Therapy for Major Depressive Disorder: Randomized Controlled Trial.基于互联网的重度抑郁症认知行为疗法的成本效用分析:随机对照试验
J Med Internet Res. 2025 Feb 19;27:e67567. doi: 10.2196/67567.
6
Methodologies and characteristics of studies investigating the cost of the palliative phase of cancer: a systematic review.研究癌症姑息治疗阶段成本的方法与特点:一项系统综述
Support Care Cancer. 2025 Jan 28;33(2):126. doi: 10.1007/s00520-025-09150-0.
7
The economic impact of living with a rare disease for children and their families: a scoping review protocol.罕见疾病对儿童及其家庭生活的经济影响:一项范围综述方案。
HRB Open Res. 2024 Apr 8;6:41. doi: 10.12688/hrbopenres.13765.2. eCollection 2023.
8
An overview of the perspectives used in health economic evaluations.卫生经济评估中所使用观点概述。
Cost Eff Resour Alloc. 2024 May 14;22(1):41. doi: 10.1186/s12962-024-00552-1.
9
Productivity costs of lifelong smoking-the Northern Finland Birth Cohort 1966 study.终生吸烟的生产力成本-芬兰北部出生队列 1966 年研究。
Eur J Public Health. 2024 Jun 7;34(3):572-577. doi: 10.1093/eurpub/ckae057.
10
Cost-effectiveness and cost-utility of the ball-and-socket trapeziometacarpal prosthesis compared to trapeziectomy and ligament reconstruction: study protocol for a randomized controlled clinical trial.球窝型腕掌关节假体与关节切除和韧带重建治疗的成本效果及成本效用比较:一项随机对照临床试验研究方案。
Trials. 2024 Mar 27;25(1):220. doi: 10.1186/s13063-024-08057-1.